Summary
This review examines recent advances in multiplex functional assays for linking human genome variants to disease phenotypes, with emphasis on applications of CRISPR/Cas9 genome editing and high-throughput sequencing. The author discusses how these experimental approaches have substantially accelerated the pace of variant characterisation relative to traditional methods, and identifies emerging strategies to enhance their clinical utility. The work sits at the intersection of genomics, molecular biology, and translational medicine rather than agricultural or food systems research.
Regional applicability
This paper is not directly applicable to UK farming systems, soil health, or food production. It addresses fundamental clinical genomics methodology relevant to human disease research but has no bearing on agricultural practice, food composition, or nutrition outcomes.
Key measures
Variant effect characterisation via multiplex functional assays; clinical significance of rare variants; phenotypic outcomes in experimental systems
Outcomes reported
The paper reviews multiplex functional assay approaches used to characterise the effects of human genetic variants on disease phenotypes. It describes how CRISPR/Cas9 genome editing and improved DNA synthesis/sequencing have enabled scalable, rapid characterisation of variant effects in experimental systems.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.